Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tielin Wu"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Although immunotherapy has revolutionized bladder cancer (BLCA) therapy, only few patients demonstrate durable clinical benefits due to the heterogeneity. Emerging evidence has linked pyroptosis to shaping tumor microenvironment (TME) and pr
Externí odkaz:
https://doaj.org/article/cc41c70262be404996dfdc1cc0cad2bd
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Recurrence of urothelial carcinoma in a patient with solitary kidney is always a clinical challenge. In the immune checkpoint inhibitor era, neoadjuvant immunotherapy in combination with the Yang–Monti technique might be a good option for the patie
Externí odkaz:
https://doaj.org/article/7147b6f2d65344cab3d01c254202307c
Publikováno v:
Urology Case Reports, Vol 41, Iss , Pp 101981- (2022)
Collecting duct carcinoma (CDC) is a rare form of renal carcinoma that has a poor prognosis. To date, there has been no report that the survival time of a patient with metastatic CDC could be more than six years. We present a case of rapidly advanced
Externí odkaz:
https://doaj.org/article/d7db24ff283447ae88453990ba6358bc
Autor:
Zhanghui Wu, Yiran Wang, Tielin Wu, Yelingyi Wang, Weipeng Chen, Chucheng Zhou, Ming Ma, Quanshui Zheng
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 11/19/2024, Vol. 121 Issue 47, p1-7, 18p
BackgroundAlthough immunotherapy has revolutionized bladder cancer (BLCA) therapy, only few patients demonstrate durable clinical benefits due to the heterogeneity. Emerging evidence has linked pyroptosis to shaping tumor microenvironment (TME) and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04e80223fdaa2a7c530e7de2d55d5766
https://doi.org/10.21203/rs.3.rs-1792638/v1
https://doi.org/10.21203/rs.3.rs-1792638/v1
